Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Solid Tumors · Primary Dysmenorrhea

Topiloric/Uriadec

Topiloric/Uriadec patent portfolio — 52 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
SOUTH SAN FRANCISCO, CA, JP HQ
2 Employees
PMDA registrant Type
Company details
Status
Public
HQ
SOUTH SAN FRANCISCO, CA, JP
Employees
2
Programs
12
Drugs
7
Patents
52
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

Topiloric/Uriadec patents

52 pharmaceutical patents indexed for Topiloric/Uriadec. 1 expire within 24 months.

Topiloric/Uriadec has 52 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

52 patents

Patent portfolio

Page 1 of 2

  1. US 12312339

    Polo like kinase 4 inhibitors

    Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12239729

    TRPV3 agonists for the treatment of skin conditions

    Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12054556

    Anti-PD-L1 antibody and use thereof

    Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12018043

    CD73 inhibitors

    Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12005080

    Method for promoting proliferation of immune cells

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11993655

    Anti-PD-L1 antibody and use thereof

    Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11858915

    Polo like kinase 4 inhibitors

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11807658

    CD73 inhibitors

    Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11576922

    CD73 inhibitors

    Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11565096

    Delivery system for a pharmaceutical, holistic or medicinal component

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11530236

    CD73 inhibitors

    Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11377469

    CD73 inhibitors

    Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11325938

    CD73 inhibitors

    Expires Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11208432

    Inhibitors of glucocorticoid receptor

    Expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11129841

    CD73 inhibitors

    Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11130778

    CD73 inhibitors

    Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11124537

    Inhibitors of glucocorticoid receptor

    Expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11110103

    Inhibitors of glucocorticoid receptor

    Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11090396

    Compounds and methods for the detection of TRPV-6 cancers and drug delivery

    Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11083635

    Tampon delivery system for a pharmaceutical, holistic or medicinal component

    Expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11028120

    CD73 inhibitors

    Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10870632

    Process for producing an extract containing tetrahydrocannabinol and cannabidiol from cannabis plant material, and cannabis extracts

    Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10864152

    TRPV3 agonists for the treatment of skin conditions

    Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10836789

    Inhibitors of glucocorticoid receptor

    Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10723759

    Inhibitors of glucocorticoid receptor

    Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10568863

    CPC distribution chromatography of cannabinoids

    Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10485841

    Method for producing dry extracts

    Expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10472387

    Inhibitors of glucocorticoid receptor

    Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10399994

    Compounds and methods for preventing or treating sensory hair cell death

    Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10064964

    Compounds and methods for the detection of TRPV-6 cancers and drug delivery

    Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10058587

    Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity

    Expires Mon Aug 23 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9980999

    Method for producing dry extracts

    Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9493482

    Compounds and methods for preventing or treating sensory hair cell death

    Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9486489

    Method for producing dry extracts

    Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9303077

    Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity

    Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9138451

    Plant extract hydrolysates and antibacterial product containing the same

    Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8962817

    Vectors encoding a paralytic peptide

    Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8895078

    Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts

    Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8734857

    Hydrolysates made of plant extracts and antibacterial agent containing the same

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8673858

    Method for treating wrinkles using a paralytic peptide from the shrew Blarina brevicauda

    Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8618058

    Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity

    Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8338136

    Method of producing a paralytic peptide

    Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8211857

    Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8003754

    Paralytic peptide for use as a insecticide

    Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7629005

    Pharmaceutical formulation consisting of a plant dry extract with a calcium coating

    Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7413754

    Use of extracts of the genus Cimicifugaas organoselective medicines for treating diseases of the genitourinary system caused by sex hormones

    Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7368534

    Myostatin and mimetics thereof

    Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 6635672

    Agent for lowering prolactin

    Expires Mon Oct 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Topiloric/Uriadec have?

52 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Topiloric/Uriadec patents expire?

1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.